Cargando…
Modulating Stress Proteins in Response to Therapeutic Interventions for Parkinson’s Disease
Parkinson’s disease (PD) is a neurodegenerative illness characterized by the degeneration of dopaminergic neurons in the substantia nigra, resulting in motor symptoms and without debilitating motors. A hallmark of this condition is the accumulation of misfolded proteins, a phenomenon that drives dis...
Autores principales: | Silvestro, Serena, Raffaele, Ivana, Mazzon, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671288/ https://www.ncbi.nlm.nih.gov/pubmed/38003423 http://dx.doi.org/10.3390/ijms242216233 |
Ejemplares similares
-
MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
por: Raffaele, Ivana, et al.
Publicado: (2023) -
Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson’s Disease
por: Schepici, Giovanni, et al.
Publicado: (2020) -
Nrf2 Activation: Involvement in Central Nervous System Traumatic Injuries. A Promising Therapeutic Target of Natural Compounds
por: Silvestro, Serena, et al.
Publicado: (2022) -
Traumatic Brain Injury and Stem Cells: An Overview of Clinical Trials, the Current Treatments and Future Therapeutic Approaches
por: Schepici, Giovanni, et al.
Publicado: (2020) -
Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application
por: Silvestro, Serena, et al.
Publicado: (2019)